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Summary The goal of our study was to obtain direct evidence of co-ordinated regulation of P-glycoprotein (P-gp)-mediated multidrug
resistance (MDR) and differentiation in tumour cells and to study some signalling pathways involved in joint regulation of these two cell
phenotypes. The sublines of human melanoma (mS) and hepatoma (human HepG2 and rat McA RH 7777) cell lines were obtained by
retroviral infection of the wild-type cells with the cDNA of the human retinoic acid receptor a (RARa). The resulting sublines stably
overexpressed exogenous RARa gene. The infectants became more differentiated than the parental cells as determined by a decrease in the
synthesis of the embryo-specific a-fetoprotein in HepG2 and McA RH 7777 hepatoma cells and by an increase in melanin synthesis in mS
cells. The differentiation of human cells was accompanied by an increase in the amounts of MDR1 mRNA but not by an increase in P-gp
activity as a drug transporter, in contrast, in the rat RARa overexpressing cells P-gp functional activity was elevated. Treatment with cytotoxic
drug (colchicine) or retinoic acid (RA) resulted in a slight increase in P-gp activity in the parental and RARa-infected melanoma cells, whereas
the increase in P-gp function in the infected hepatoma cells (both human and rat) was very prominent. Thus, we provide new evidence that
cell differentiation caused by the overexpression of the gene participating in the differentiation programme leads to overexpression of MDR1
gene and drug resistance and that this effect is tissue and species specific. These data implythat the activation of the RA-controlled signalling
pathway up-regulates MDR1 gene expression.
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Cancer cells may undergo various phenotypic changes in the
course oftumour progression. Chemotherapy and y-irradiation can
also evoke different genetic and epigenetic alterations in the char-
acteristics ofa tumour. Among these changes, multidrug resistance
(MDR) is of utmost clinical significance. The phenomenon of
MDR is considered as one of the major reasons for therapeutic
failures in patients with different malignancies. P-glycoprotein (P-
gp), atransmembrane pump capable ofeffluxing various lipophilic
substances from the cell, is one ofthe pivotal mechanisms ofclin-
ical MDR. P-gp is encoded by the MDR family genes, the mdrlb
and mdr3 in rodents and MDR] in humans (Roninson, 1991).
Expression of P-gp has been shown to be tissue specific
(Gottesman et al, 1991) and can be elevated either by transient
exposure of tumour cells to chemotherapeutic drugs, UV and y-
irradiation, heavy metals and protein kinase C agonists (Chin et al,
1990a,b, 1992; Licht et al, 1991; Chaudhary and Roninson, 1992,
1993) or by prolonged selection by cytotoxic agents (reviewed in
Beck and Danks, 1991; Sugimoto and Tsuruo, 1991).
An association ofdifferentiation status ofthe cell with its sensi-
tivity to cytotoxic agents is under investigation. In earlier studies,
it has been shown that the MDR] gene was overexpressed in more
differentiated areas oftumours (Mickley et al, 1989). Furthermore,
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agents inducing cell differentiation such as all-trans-retinoic acid
(RA), dimethylsulphoxide and sodium butyrate increased steady-
state levels of MDR] mRNA in various cell types (Bates et al,
1989; Mickley et al, 1989). Also, cells of different tissue origin
selected in vitro for P-gp-mediated MDR have often been shown
to possess higher degrees of differentiation than their parental
counterparts (Stavrovskaya et al, 1990; Alekseevskaya et al, 1993;
Biedler and Spengler, 1994). In addition, these MDR sublines
were more sensitive to induction ofdifferentiation (Djuraeva et al,
1991; Stromskaya et al, 1995a).
However, in all these studies, only correlations between MDR
and differentiation were investigated; direct evidence that the
occurrence ofdifferentiation causes MDR is absent. The signalling
pathways participating in co-ordinated regulation of cell differen-
tiation, MDRJ gene expression and drug resistance are unknown.
Meanwhile, the alterations of the phenotype of MDR cells are
numerous (Biedler and Spengler, 1994) and it cannot be excluded
that changes in cell differentiation are connected not directly with
MDR but with other cell changes. MDR] gene expression can be
up-regulated by a wide range of chemicals and differentiation
agents are only a small proportion of them (Chaudhary and
Roninson, 1993). This does not suggest that: the influence of
differentiating agents on differentiation and MDR] expression is
very specific.
In an attempt to obtain direct evidence of the connection
between cell differentiation and MDR, we used a new approach.
We obtained more differentiated cells by introduction of the gene
that triggers cell differentiation and looked for different mecha-
nisms ofMDR in the stably transfected cells. Full-length cDNA of
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the human RARa was introduced by retroviral infection into
several types of recipient cells. The markers of differentiation, as
well as MDR] expression and P-gp functional activity, were A
analysed in parental cells and in stable infectants in the course of
treatment with RA or colchicine (CH). Our data demonstrate that
(a) infection with exogenous RARa renders the cells more differ-::
entiated and precommitted to the differentiating effect of RA; (b)>.A
up-regulation of MDR] expression in RARa-infectants is regis-
tered; (c) MDR] expression and P-gp function are more inducible
in the infectants than in parental cells; (d) the mechanisms of
differentiation-induced up-regulation of the MDR phenotype are
species and tissue specific; and (e) RA-controlled signalling
pathway up-regulates both cell differentiation and MDR] expres-
sion but does not influence P-gp functional activity as a drug-
effluxing pump in human cells.
MATERIALS AND METHODS
Cell lines and drugs
B
Human hepatocarcinoma HepG2 (Becker et al, 1976), human
melanoma mS (Stromskaya et al, 1995a) and rat hepatoma McA
RH 7777 (Knowles et al, 1980) cell lines were propagated in
RPMI-1640 medium (Flow, UK) supplemented with 10% fetal
calf serum (Gibco BRL, Grand Island, USA), 2 mM L-glutamine,
50 U ml-1 gentamycin. CH (Merck, Germany) was dissolved in
sterile deionized water and kept at -40C until the experiments
were started. RA (Sigma, USA) was dissolved in ethanol and kept
at -4°C until the experiments were started.
Expression vector and retroviral infection
The PA317/LRARSN retroviral vector-producing cell line was a
generous gift from Dr SJ Collins (Fred Hutchinson Cancer
Research Center, Seattle, WA, USA). The vector contains a cDNA
fragment harbouring the complete coding sequence of the RAR-ai
gene driven by the Moloney murine leukaemia virus long-terminal C
repeat as well as the SV40 early promoter-driving neomycin phos- ii,3 ,
photransferase gene (neo) as a selectable marker (Collins et al,
1990). The cells (4 x 105 per25-cm2 flask) were seeded 24 h before
infection. Conditioned medium from a retrovirus-producing cell
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Figure 2 Transmission electron microscopy of mS and mS/RAR cells.
Figure 1 RARa transcripts in uninfected and LRARSN (RARa) infected (A) A fragment of mS cell showing premelanosomes of various stages of
cells. Total RNA was hybridized with a human RARa-specific probe (see melanogenesis; the majority of premelanosomes contain the fibrils with
Materials and methods). The 3.3- and 2.5-kb endogenous RARa transcripts internal helical-transverse periodicity (x 15 000). (B) A fragment of mS/RAR
as well as the 4.9- and 3.1-kb LRARSN-expressed RARa transcripts are cell with premelanosomes and melanosomes of late stages of maturation
indicated. Lanes: 1, Hep/RAR; 2, Hep/neo; 3, mS/RAR; 4, 7777/RAR. The (x 18 750). (C) A fragment of mS/RAR cell treated with RA (5gM for 48 h)
quantity of RNA applied: lanes 1, 3, 4, 20 gg; lane 2, 40 9g and showing numerous electron-dense melanosomes (x 15 000)
British Journal ofCancer(1998) 77(11), 1718-1725 0 CancerResearch Campaign 19981720 TP Stromskaya etal
100-
.75- i il R~
o 50 - 4
25-
Hep/neo Hep RAR 7777/neo 7777/RAR
Figure 3 Immunochemical detection of AFP in hepatoma cells. The assay
for AFP content is described in Materials and methods. The percentage of the
colonies with different amounts of AFP is given. The experiments were
repeated three times with similar results. *, APP+; U, mixed clores; 1i,
APP-
line was filtered through a 0.45-jim membrane (Millipore, USA),
diluted 1:1 with medium containing 1% serum and 8 jg ml
Polybrene and added to the cells for 24 h at 370C, 5% carbon
dioxide. Further selection was carried out by culturing the cells in
medium supplemented with 400 jig ml G418 for at least 21 days.
The medium was changed twice a week. The pool of colonies of
G418-resistant cells was resuspended in culture medium and
progressively expanded.
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Analysis of rhodamine 123 (Rh123) efflux
Cells were detached from the culture plastic, loaded with 5 jg ml-
Rhl23 (Sigma) for 10 min at 37°C, washed twice with cold PBS,
pH 7.2, and incubated for 30 min in dye-free medium at 37°C.
After the completion of incubation, cells were washed twice with
cold PBS. Cell fluorescence was measured on a flow cytometer
FACScan (Becton Dickinson, USA). Each measurement counted
5000 events. Non-viable cells were gated out ofthe analysis on the
basis of side scatter.
RNA isolation and reverse transcriptase polymerase
chain reaction (RT-PCR) analysis of MDR1 gene
expression
The cells were lysed in TRIzol reagent (Gibco BRL). Total RNA
was isolated as described in the manufacturer's manual. For quali-
tative analysis, aliquots of isolated RNA were denatured with
formamide and subjected to electrophoresis in 1.8% agarose gels.
The samples with clearly visualized 18S and 28S RNA bands were
used for further procedures. First-strand cDNA was synthesized
using the Superscript Preamplification System (Gibco BRL) with
0.5-1.0 jg RNA as a template, 2.5 ng ml-' random hexamers,
0.5 mM ofeach deoxynucleotide triphosphate, 10 mm dithiothreitol
and 10 U ul-l Superscript RT. The reaction was performed at 42°C
for 50 min followed by inactivation of the enzyme at 70°C for
15 min. The samples were treated with 0.1 U jl-l Escherichia coli
RNAase H for 20 min at 37°C, boiled and kept at -200C.
Quantitative PCR analysis of MDRJ gene expression was
performed using oligomers amplifying a 167-bp product; the
amounts of template cDNAs were normalized by PCR
amplification of P2-microglobulin cDNA (internal control)
(Noonan and Roninson, 1991). The optimal numbers of PCR
cycles were 26 for the MDRJ-specific product and 20 for the
Figure 4 PCR analysis and the densitometry of MDR1 mRNA expression.
(A) Sublines of mS cells: 1, mS; 2, mS treated with RA (5 gM, 48 h); 3, mS
treated with CH (10 ng ml-', 24 h); 4, mS/RAR; 5, mS/RAR treated with RA;
6, mS/RAR treated with CH. (B) Sublines of HepG2 cells: 1, Hep/neo; 2,
Hep/neo treated with RA; 3, Hep/neo treated with CH; 4, Hep/RAR; 5,
Hep/RAR treated with RA; 6, Hep/RAR treated with CH. The 167-bp product
band corresponds to MDR1; the 120-bp band corresponds to 02-
microglobulin-specific product (internal control). The density of MDR1 and 02-
microglobulin bands were quantified by densitometric scanning on UltroScan
Laser Densitometer LKB2202. The results are expressed as the ratio of
MDR1 mRNA to 02-microglobulin mRNA. One out of two experiments with
similar results is presented
P2-microglobulin-specific one. These numbers of cycles yielded
clearly detectable PCR products within an exponential range. PCR
products were amplified in separate tubes, mixed, resolved by elec-
trophoresis in 7.5% polyacrylamide gel, stained with ethidium
bromide, visualized in UV light and analysed by densitometry.
Northern blot analysis
Total RNA was separated in 1% agarose gel under denaturing
conditions according to the method of Lehrach et al (1977). RNA
was transferred onto Hybond-N nylon membrane (Amersham,
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Buckinghamshire, UK). Nylon membrane was allowed to dry at
room temperature and was baked for 1 h at 80°C in a vacuum
oven. Blots was hybridized with 32P-labelled DNA-RARa probe as
described by Maniatis et al (1982). The plasmid containing a
human RARa cDNA used for 32P-labelled probe was provided by
Dr SJ Collins (Fred Hutchinson Cancer Research Center). After
hybridization, the washed blot was exposed for autoradiography.
Study of cytotoxicity
The sensitivity of parental cell lines and RARcx infectants to CH
was determined by the colony formation assay. The cells
(2-5 x 102) were plated onto 60-mm dishes in the medium
containing different concentrations of CH and incubated for 14
days. The medium was changed twice a week. The colonies of
surviving cells were Giemsa stained. Cell survival was estimated
as the ratio ofthe number ofcolonies at a given dose ofCH to that
in control (CH-free) dishes.
Transmission electron microscopy
The mS cells and theirRARa-infected counterparts were grown on
glass coverslips for 2 days, fixed with 2.5% glutaraldehyde in
PBS, post-fixed in 1% osmium tetroxide, dehydrated in a graded
ethanol series and embedded into Epon-812. Ultrathin sections
were stained sequentially with uranyl acetate and lead citrate and
examined in a Geol Elmiscop (GEM-1200exII) at 80 kV.
The analysis of oa-fetoprotein (AFP) expression
Immunochemical detection ofAFP in HepG2, McA RH 7777 and
their RARa-infected variants was performed essentially as
described previously (Alekseevskaya et al, 1992). Primary rabbit
anti-AFP antibody was a gift from Dr T Eraiser (Cancer Research
Centre, Moscow, Russia). Peroxidase-conjugated goat anti-rabbit
IgG was used as a secondary antibody. AFP-expressed cells were
visualized by enzymatic conversion of diaminobenzidine tetra-
chloride. The colonies were considered AFP positive (100%
stained cells), negative (no staining) or mixed (containing both
staining and non-stained variants). Two hundred colonies were
counted for each determination.
RESULTS
Expression of exogenous RARa gene in the infected
cells
Full-length cDNA of the human RARa was introduced into the
inS, HepG2 or McA RH 7777 cells by means of retroviral infec-
tion and the sublines mS/RAR, Hep/RAR and 7777/RAR were
established. These sublines were isolated as a pool of infected
clones in order to avoid clonal variability. The control cells in our
experiments were represented by the parental (non-infected)
cultures as well as by the sublines with the vector expressing the
neo gene alone and selected for G418 resistance (neo infectants).
Transduction of the neo gene alone did not change any of the
studied characteristics of the cells, e.g. markers of differentiation,
constitutive or inducible levels of MDR] mRNA or P-gp activity
compared with non-infected cells (data not shown). To confirm
that the exogenous RARa is expressed in G418-resistant cell vari-
ants, total RNA from control (neo infected) and RARa-infected
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Figure 5 Rh123 efflux by control and RARa-infected cells. Flow
cytometrical analysis of Rhl23 efflux was performed as described in
Materials and methods. Logarithmic fluorescence profiles of RARa-infected
cells (-) and mock-infected (control, - - -). (A) mS and mS/RAR cells;
(B) Hep/neo and Hep/RAR cells; (C) 7777/neo and 7777/RAR cells. One
representative experiment out of two is shown
sublines was hybridized with the fragment of human RARat
cDNA. Figure 1 demonstrates the presence of the exogenous
RARax transcripts in the sublines of infected cells. These infected
cells express the retroviral 4.9 and 3.1 kb RARa transcripts (lanes
1, 3 and 4). The mRNA expression ofthe endogenous RARax tran-
scripts in human cells Hep/neo is also visible (lane 2).
Differentiation and proliferation of RARa-infected cells
The ability to produce melanin is usually considered as amarkerof
differentiation in melanoma cells (Filippova et al, 1983; Mishima
and Imokawa, 1986). To analyse whether the mS and mS/RAR
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Figure 6 Influence of RA and CH on Rh123 efflux by control and RARa-infected cells. Rh123 efflux was analysed after treatment of cells with RA (5gM, 48 h)
(top) and CH (10 ng ml-', 24 h) (bottom). Shown are logarithmic fluorescence profiles of untreated cells --- -) and treated cells (-). One out of two experiments
with similar results is presented
cells differ in the production ofmelanin, we studied these sublines
using transmission electron microscopy. The mS/RAR cells
became more differentiated as electron microscopy revealed larger
quantities of mature premelanosomes in RARa-transformed cells
than in their parental counterparts (Figure 2A and B). Moreover,
RA, a known inducer of melanocyte differentiation, exerted
different effects on the parental and RARa-infected cells.
Treatment of the mS cells with RA (5 ,UM, 48 h) did not influence
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the differentiation of the cells; in contrast, under the same treat-
ment mS/RAR cells demonstrated an increased number of pre-
melanosomes at all stages of maturation as well as elevation of
pigment content (Figure 2C).
We next studied whether the infection of hepatoma cell lines
with RARa affects the number ofcells producing AFP, a markerof
hepatocytes in early embryo development. Plating at a low density
of the control Hep/neo and 7777/neo resulted in the growth of
either AFP-producing (AFP+) or AFP-negative clones (AFP-) as
well as the occurrence of the colonies with both AFP+ and AFP-
cells (mixed clones). As shown in Figure 3, the number of AFP+
clones significantly decreased in Hep/RAR compared with
Hep/neo; also, AFP+ cells almost disappeared from 7777/RAR
sublines. These data suggest that the production ofAFP is at least
partially suppressed in the RARa-infected hepatoma cells.
The RARa-infected human cells proliferated more slowly than
the parental cells. The doubling time of mS/RAR and Hep/RAR
cells increased in comparison with parental cells (60 h vs 40 h for
melanoma cells and 60 h vs 24 h for hepatoma cells), whereas the
doubling times of rat 7777/RAR and their parental cells were
similar (approximately 24 h). Taken together with the results of
ultramicroscopical and immunocytochemical assays, our data
indicate that overexpression of exogenous RARax rendered the
infectants more differentiated.
MDR1 gene expression in RARa-infected human cells
We next determined the constitutive and inducible levels ofMDRI
mRNA in RARa-infected sublines. RT-PCR analysis revealed an
increase in the steady-state levels ofMDR] transcripts in mS/RAR
and Hep/RAR compared with mS and Hep/neo respectively
(Figures 4A and 4B, compare lanes 1 and 4). Treatment with RA
(5 gM, 48 h) resulted in elevation of MDR] mRNA levels both in
the mS and in the mS/RAR cells (Figure 4A, lanes 2 and 5). The
same effect was observed with Hep/neo (Figure 4B, lane 2). The
degree of induction was higher in mS/RAR cells, suggesting that
in mS/RAR cells the MDRJ gene became more inducible by RA.
In contrast, the levels of MDR] mRNA in RA-treated Hep/RAR
cells were not higher than in Hep/neo (Figure 4B, lanes 5 and 2).
Thus, we did not show the elevation of inducibility of the MDR]
gene by RA treatment in hepatoma cells.
CH is a P-gp-transported drug shown to induce MDRJ gene
expression in some cell types (Kohno et al, 1989; Chaudhary and
Roninson, 1993). Figure 4A (lanes 3 and 6) shows that CH
(10 ng ml-1, 24 h) did not elevate MDRI expression in mS or in
mS/RAR cells. However, CH-treated Hep/neo and Hep/RAR cells
showed elevation ofMDR] mRNA expression (Figure 4B, lanes 3
and 6). It is noteworthy that the increase in MDR] mRNA in the
control Hep/neo treated with CH was significantly greater than in
mS treated with the same drugs (Figure 4B, lane 3, compare with
Figure 4A, lane 3). This difference may be connected with the
tissue origin ofthe cells: itis known thatthe level ofMDR] expres-
sion in the liver is comparatively high, whereas the skin is charac-
terized by low amounts ofMDR] mRNA (Gottesman et al, 1991).
P-gp activity in the parental and RARa-infected cells
P-gp functional activity was measured by means of FACScan
analysis ofRhl23 efflux from the cells (Neyfakh, 1988). Rhl23 is
a fluorescent dye that is transported by P-gp out of the cells. The
cells with P-gp-mediated MDR exclude Rhl23 at a higher rate
than drug-sensitive variants; so, the analysis of cell fluorescence
after removal ofRhl23 from culture medium permits the compar-
ison of P-gp functional activity in different cell populations. The
Rhl23 technique is very sensitive and allows the detection of
initial alterations in P-gp activity (Chaudhary and Roninson, 1992;
Egudina et al, 1993).
The results of flow cytometric experiments are presented in
Figure 5. Neither of the human RARa-infected cell lines studied
demonstrated a higher rate of Rhl23 efflux than their parental
counterparts (Figure 5A and B). In contrast, the comparison ofrat
hepatoma cells shows that 7777/RAR contained significantly
higher amounts of Rhl23-dull cells than 7777/neo (Figure SC).
This shows that overexpression of RARca did not change P-gp
activity in the two studied human cell lines but did change it in the
rat cells.
Treatment ofRARa-infected cells with RA (5 gM, 48 h) led to a
dramatic increase in the number of Rhl23-dull variants (Figure
6D-F). The effects were demonstrated for all studied cell lines,
regardless of their species and tissue origin. However, the induc-
tion of P-gp-mediated efflux by RA in mS/RAR cells was less
pronounced than that in Hep/RAR or 7777/RAR variants
(compare Figure 6D with E and F). Interestingly, treatment of all
parental cells with RA did not cause any discernible changes in
P-gp function (Figure 6A-C).
CH (10 ng ml-1, 24 h) elevated P-gp functional activity in the
control cell populations to a greater degree than RA, especially in
7777/neo culture (Figure 6G-I). The effect ofCH on P-gp activity
was much more pronounced in RARa infectants (Figure 6J-L).
Again, as with RA treatment, the effect ofCH on melanoma cells
was lower than in other studied sublines. This elevation of
inducibility ofRARa-infected cells did notnecessarily result in the
acquisition of CH resistance: the comparison of mS and HepG2
sensitivity with CH revealed an almost identical IC50 for parental
and infected cells (2-4 ng ml-1 CH for both cell types). However,
RARa-infected rat cells (7777/RAR) became twofold resistant to
CH than 7777/neo cells (IC50 for7777/neo cells was 5 ng ml-', and
11 ng ml-' for 7777/RAR cells). These data are in agreement with
our results on differences in Rhl23 efflux by parental cells and
their RARa-infected counterparts.
Thus, our data show that the RARa gene increases MDR]
expression but not P-gp activity in transfected cells. However the
RARa gene elevates inducibility ofthe function of this protein by
the ligand ofthe RARa (RA) and by the cytotoxic drug (CH).
DISCUSSION
The goal of our study was to obtain direct evidence of co-ordi-
nated regulation of P-gp-mediated MDR and differentiation in
tumour cells and to study some signalling pathways involved in
joint regulation of these two cell phenotypes. Previous data show
that differentiation and MDR might be connected and that
MDRJ/P-gp expression may be part of the differentiation
programme of the cell. However, further studies are needed to
prove this supposition (discussed in the Introduction). In this
study, we created more differentiated cells by introduction of the
gene involved into the cell differentiation programme and investi-
gated the various mechanisms of MDR, i.e. MDRJ expression,
P-gp functional activity and cell resistance to the cytostatic drug.
We isolated the sublines of tumour cells of different species
(human and rat) and tissue (hepatoma and melanoma) origin after
infection with full-length cDNA oftheRARcx gene. These sublines
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were shown to express transgene. As expected, these sublines
demonstrated the patterns of more differentiated phenotypes
compared with mock-infected counterparts. Elevated amounts of
melanin were observed in RARx-infected melanocytes; the level
of AFP, an embryo-specific liver protein, was decreased in
infected hepatocytes. The rate ofproliferation ofall studied human
RARa-infectants was slower than that ofparental cells. In addition,
RARax-overexpressing cells appeared to be more sensitive to the
induction ofdifferentiation by RA.
The study of MDR] gene expression using the highly sensitive
RT-PCR technique showed the increased amounts of MDRJ
mRNA in RARa-infected human cells. These data suggest that
overexpression of RARc is the cause of constitutive activation of
the MDR] gene and/or increase in the stability ofMDRJ mRNA.
Our results contrast with previous studies (Teeter et al, 1991) that
have shown down-regulation of MDR] promoter activity after
transient co-transfection of Chinese hamster ovary (CHO) cells
with RARax- orRARP-expressing vectors together with the MDRJ
promoter region-chloramphenicol acetyltransferase reporter
construction. The discrepancy between these and our results could
be due to the different cell types used in the experiments.
Moreover, the mechanisms of overexpression of an exogenous
gene in transiently and stably infected cells may vary (Kopnin et
al, 1995; Stromskaya et al, 1995b).
We next investigated whether elevated levels ofMDRJ mRNA
render RARac-infectants more resistant to P-gp-transported
compounds. This was studied using two methods: (a) flow cyto-
metric analysis ofthe efflux ofRh123, a fluorescent dye with high
affinity for P-gp, and (b) survival of the cells in the continuous
presence of CH, a P-gp substrate. However, neither method
revealed any activation of P-gp function in human RARa-infec-
tants. These data indicate that overexpression of RARax does not
lead to the emergence ofthe MDR phenotype, despite the increase
in steady-state levels of MDRJ mRNA. Several explanations of
these data may be proposed. First, the increase in the MDR]
message is too low to confer discernible levels of MDR. Second,
P-gp synthesis may undergo post-transcriptional changes; also,
post-translational modifications such as phosphorylation or glyco-
sylation may regulate P-gp-mediated drug transport. In addition,
one cannot rule out the possibility that the transport ofmature P-gp
from the Golgi apparatus might be affected inRARcx infectants. An
alternative possibility is that in RARa-infected cells, P-gp has a
function unrelated to drug efflux. It is noteworthy that treatment of
human neuroblastoma cells with RA induced differentiation and a
concomitant overexpression of P-gp, whereas intracellular accu-
mulation of vinblastine, vincristine or actinomycin D was not
decreased (Bates et al, 1989). Together with our results, these data
suggest that RA-activated signal transduction causes up-regulation
of MDRJ gene expression but does not influence P-gp-mediated
drug efflux. Ifthat is the case, P-gp might have other physiological
functions in the differentiated cells. It has been postulated that P-
gp as well as other ATP-binding cassette transporters can regulate
heterologous membrane channels and, perhaps, other membrane
proteins (Bates et al, 1989). Probably, in the differentiated cells, P-
gp acts as such a regulator or fulfils other functions that are neces-
sary for maintenance of the differentiated phenotype. Recent data
suggest that P-gp can function as a lipid flippase of broad speci-
ficity that translocates phospholipids across membranes (van
Helvoort et al, 1996).
Although the transport ofP-gp substrates in non-stimulatedRARax
inlfectants was unlaffected, these sulh]ines were mrore senasitive to the
induction of Rh123 efflux by RA or CH than were parental cells.
This activation appeared to be tissue and species specific. In the mS
and mS/RAR cells, both CH and RA caused only a slight increase in
Rh123 efflux. The continuous exposure ofHep/RAR cells to RA or
CH resulted in the significant activation of Rh123 efflux. In the
7777/RAR cells the rate of induction was even higher. Moreover,
only these cells among all RARa infectants demonstrated occur-
rence of drug resistance. These data testify that the effects of the
overexpression of RARca on MDR] expression, P-gp transport and
MDR are strongly dependent on cell context and are tissue and
species specific.
In conclusion, our data provide new evidence that cell differen-
tiation induced by the overexpression of the gene participating in
the differentiation programme results in overexpression of the
MDR] gene and may lead in some cells to elevation ofP-gp func-
tional activity and drug resistance. Prolonged treatment of RARax-
infectants with CH or RA resulted in the increase in both MDR]
mRNA abundance and Rh123 efflux to a greater extent than in the
parental cells. Thus, RARa activation increases MDRJ expression
and elevates inducibility ofthe function ofthis protein by the cyto-
toxic drug (CH) and activator (RA) of the transgene. These data
imply that differentiation therapy may evoke an important conse-
quence: it may cause the emergence of the MDR phenotype in a
portion of the tumour population. Genes involved in cell differen-
tiation and activated in the course of the therapy may elevate the
rate ofMDRI/P-gp response to cytotoxic drugs and thus give these
cells selective advantage for survival in the course of
chemotherapy.
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